A randomized phase II/III study of paclitaxel/carboplatin/metformin versus paclitaxel/carboplatin/placebo as initial therapy for measurable stage III or IVA, stage IVB, or recurrent endometrial cancer: An NRG Oncology/GOG study
Victoria Bae‐Jump, Michael W. Sill, Paola A. Gehrig, K. Moxley, Andrea R. Hagemann, Steven Waggoner, Roisin E. O’Cearbhaill, M. McDonald, Paul DiSilvestro, Paul W. Sperduto, Carol Aghajanian
Topics & Concepts
CarboplatinMedicinePaclitaxelEndometrial cancerOncologyTolerabilityInternal medicineMetforminPlaceboStage (stratigraphy)ChemotherapyCancerGynecologyCisplatinAdverse effectBiologyInsulinAlternative medicinePaleontologyPathologyMetabolism, Diabetes, and CancerCancer, Lipids, and MetabolismEndometrial and Cervical Cancer Treatments